Promotie onderzoek

The aim of this project is to explore the 3D printing of peadiatric medicines. 3D printing technology enables the creation of medications with a wide range of dosages, shapes, flavors, and drug combinations, all customized to meet the unique needs of individual patients and specific disease conditions. Once the optimal formulations have been developed, the 3D printed medicines will undergo clinical trials for testing. 

We will study compounding medication by 3D printing technology. In this way personalized medication will become more accessable. 
First formulation studies will be executed in order to provide a stable production process. After which, the use of 3D printing will be introduced in the clinical setting. Finally, the printed medication will be tested by a clinical trial.
 

We aim to develop methods to radiolabel orally inhaled drug products, allowing us to more accurately determine lung deposition through imaging techniques. 
 

To describe the impact of COVID-19 on the continuity of care in the primary care setting.
To describe the impact of delirium and frailty on clinical outcomes in COVID-19 patients admitted to the hospital.
To describe the impact of delirium on recovery of COVID-19 patients in geriatric rehabilitation.
To describe perceptions, motivations, needs and experiences of geriatricians with scientific research.
 

My research focuses on the socioeconomic determinants of psychotropic medication use in children and adolescents. Specifically, I aim to identify the complex relationships between socioeconomic factors and psychotropic medication use in young people, and to explore potential avenues for improving health outcomes in this vulnerable population.